BeStock  

3D Systems DDD

US equityMarket cap rank #3661Computer Hardware3D Printing
$3.41 −$0.18 (-5.01%)
Pre-market · Oct 8, 8:00 am ET · After hours $3.41 0.00%
Open$3.51
Prev close$3.59
Day range$3.36 – $3.54
Volume2.08M
Market cap$566.56M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership76.3%+0.02 pts vs. prior quarter
Institutions holding242-1 vs. prior quarter
Insider trades (recent)22 buys / 28 sellsNet selling
Short interest26.45% of floatDays to cover 21.3 · as of 15 Sep 2026
Short-sale volume share18.7%5-day average of daily volume

Short-sale volume as % of daily volume

9%15%21%26%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$923.7K (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

+$144.5KSuper+$779.1KBig+$169.0KMid−$132.8KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 29.2% of shares outstanding.

Largest holders

  • BlackRock8.18%
  • State Street Global Advisors7.99%
  • Vanguard Capital Management, LLC4.70%
  • Aigh Capital Management, LLC4.38%
  • Two Sigma Investments, LP3.95%
  • The Bank of Nova Scotia3.16%
  • D. E. Shaw & Co., L.P.2.56%
  • Marshall Wace LLP2.37%

By investor type

  • Mutual Fund43.62%
  • Hedge Fund22.39%
  • Public Company5.52%
  • Individual/Insider3.43%
  • Private Company1.85%
  • Insurance Company1.67%
  • Family Office/Trust1.16%
  • Government Pension Fund0.08%

Reported short interest has fallen from 27.27% to 26.45% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Nuveen Asset Management LLC Insurance Company 2026/Q3 +1,038,899 1.7%
Aigh Capital Management, LLC Hedge Fund 2026/Q3 +7,271,000 4.4%
Needham Investment Management, LLC Mutual Fund 2026/Q3 +3,525,200 2.1%
Medina Value Partners, LLC Hedge Fund 2026/Q3 +3,279,375 2.0%
BlackRock Mutual Fund 2026/Q3 +2,752,009 8.2%
Acadian Asset Management LLC Mutual Fund 2026/Q3 +2,682,326 1.7%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +1,899,587 1.3%
State Street Global Advisors Mutual Fund 2026/Q3 +1,788,024 8.0%
Balyasny Asset Management L.P. Hedge Fund 2026/Q3 +1,743,802 1.1%
Archon Capital Management LLC Hedge Fund 2026/Q3 +1,200,000 1.1%
PanAgora Asset Management, Inc. Mutual Fund 2026/Q3 +1,173,903 0.7%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +1,086,070 1.8%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +1,054,865 4.7%
JPMorgan Chase & Co. Public Company 2026/Q3 +877,212 0.6%
PGIM, Inc. Mutual Fund 2026/Q3 +848,750 0.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
16 Sep 2026 Jeffrey Graves Chief Executive Officer Open Market Disposition -42,686 $3.55 1,231,596
16 Sep 2026 Phyllis Nordstrom Executive VP, Chief People Officer & Chief Administrative Officer Open Market Disposition -30,000 $3.58 715,871
7 Sep 2026 Charles Hull Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus Sale to Issuer -4,943 $3.38 513,577
7 Sep 2026 Jeffrey Graves Chief Executive Officer Sale to Issuer -39,959 $3.38 1,274,282
7 Sep 2026 Phyllis Nordstrom Executive VP, Chief People Officer & Chief Administrative Officer Sale to Issuer -47,396 $3.38 745,871
7 Sep 2026 Andrew Wright Senior VP of General Counsel & Corporate Secretary Sale to Issuer -5,818 $3.38 136,963
7 Sep 2026 Reji Puthenveetil Executive Vice President of Industrial Solutions Sale to Issuer -15,984 $3.38 486,144
7 Sep 2026 Joseph Zuiker Executive Vice President of Engineering & Operations Sale to Issuer -6,689 $3.38 271,362
19 Aug 2026 Jeffrey Graves Chief Executive Officer Open Market Disposition -115,500 $3.26 1,314,241
13 May 2026 Jim Kever Independent Director Other Acquisition +45,731 – 560,650
13 May 2026 Thomas Erickson Independent Director Other Acquisition +45,731 – 395,178
13 May 2026 Kevin Moore Independent Director Other Acquisition +45,731 – 317,427
13 May 2026 Charles McClure Independent Chairperson Other Acquisition +45,731 – 227,848
13 May 2026 John Tracy Independent Director Other Acquisition +45,731 – 226,442
13 May 2026 Malissia Clinton Independent Director Other Acquisition +45,731 – 200,669
13 May 2026 Vasant Padmanabhan Independent Director Other Acquisition +45,731 – 192,915
13 May 2026 Claudia Drayton Independent Director Other Acquisition +45,731 – 174,369
13 Apr 2026 Charles Hull Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus Sale to Issuer -4,102 $1.98 518,520
13 Apr 2026 Jeffrey Graves Chief Executive Officer Sale to Issuer -30,500 $1.98 1,429,741
13 Apr 2026 Phyllis Nordstrom Executive VP, Chief People Officer & Chief Administrative Officer Sale to Issuer -1,626 $1.98 793,267

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 43,937,708 26.4% 21.3
31 Aug 2026 43,721,595 26.3% 22.7
14 Aug 2026 43,582,815 26.2% 8.2
31 Jul 2026 43,619,761 26.7% 22.1
15 Jul 2026 44,171,556 27.0% 16.5
30 Jun 2026 44,542,920 27.3% 9.5

Discussion

No comments yet — be the first to weigh in on DDD.

Leave a comment

Scroll to Top